16 results
424B2
PLSE
Pulse Biosciences Inc
4 Jun 24
Prospectus for primary offering
4:05pm
regulatory review of high-risk devices. The EU MDR also envisages greater control over notified bodies and their standards, increased transparency
POS AM
PLSE
Pulse Biosciences Inc
28 May 24
Prospectus update (post-effective amendment)
5:19pm
review of high-risk devices. The EU MDR also envisages greater control over notified bodies and their standards, increased transparency, more robust
10-K
z76e dcyt51uq71
20 Mar 17
Annual report
12:00am
- Prev
- 1
- Next